Straits Times Index
3,269.27 -32.69 (-0.99%) Nikkei
28,546.98 +727.65 (+2.62%) Hang Seng
20,175.62 +93.19 (+0.46%) FTSE 100
7,500.89 +34.98 (+0.47%) BTC-USD
24,550.26 +472.40 (+1.96%) CMC Crypto 200
574.64 +3.36 (+0.59%)
LLY Sep 2022 310.000 call
| Previous close | 6.95 |
| Open | 8.00 |
| Bid | 9.30 |
| Ask | 10.10 |
| Strike | 310.00 |
| Expiry date | 2022-09-16 |
| Day's range | 6.90 - 10.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 671 |
- Zacks
Top Stock Reports for Eli Lilly, CVS Health & Target
Today's Research Daily features new research reports on 12 major stocks, including Eli Lilly and Company (LLY), CVS Health Corporation (CVS), and Target Corporation (TGT)
- Zacks
Karuna (KRTX) Stock Skyrockets 98.7% in a Month: Here's Why
Karuna Therapeutics (KRTX) is progressing well with its pipeline development. KRTX's lead candidate meets late-stage study goals as a potential treatment for adults with schizophrenia.
- Motley Fool
2 Dividend Stocks That Are Defying the Bear Market
Two dividend stocks that have been beating the markets by wide margins this year include Eli Lilly (NYSE: LLY) and ExxonMobil (NYSE: XOM). Drugmaker Eli Lilly has seen its share price rise 9% thus far in 2022. This month, Eli Lilly released its second-quarter numbers, which showed sales of $6.5 billion for the period ended June 30, down 4% year over year; however, this falls to a decline of just 1% when factoring out the impact of foreign currency exchange.
